These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

222 related articles for article (PubMed ID: 28760905)

  • 21. Selective inhibition of HIV-1 reverse transcriptase-associated ribonuclease H activity by hydroxylated tropolones.
    Budihas SR; Gorshkova I; Gaidamakov S; Wamiru A; Bona MK; Parniak MA; Crouch RJ; McMahon JB; Beutler JA; Le Grice SF
    Nucleic Acids Res; 2005; 33(4):1249-56. PubMed ID: 15741178
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Structure of a dihydroxycoumarin active-site inhibitor in complex with the RNase H domain of HIV-1 reverse transcriptase and structure-activity analysis of inhibitor analogs.
    Himmel DM; Myshakina NS; Ilina T; Van Ry A; Ho WC; Parniak MA; Arnold E
    J Mol Biol; 2014 Jul; 426(14):2617-31. PubMed ID: 24840303
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Inhibition of the DNA polymerase and RNase H activities of HIV-1 reverse transcriptase and HIV-1 replication by Brasenia schreberi (Junsai) and Petasites japonicus (Fuki) components.
    Hisayoshi T; Shinomura M; Yokokawa K; Kuze I; Konishi A; Kawaji K; Kodama EN; Hata K; Takahashi S; Nirasawa S; Sakuda S; Yasukawa K
    J Nat Med; 2015 Jul; 69(3):432-40. PubMed ID: 25663480
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Uvaria angolensis as a promising source of inhibitors of HIV-1 RT-associated RNA-dependent DNA polymerase and RNase H functions.
    Ngoutane Mfopa A; Corona A; Eloh K; Tramontano E; Frau A; Boyom FF; Caboni P; Tocco G
    Nat Prod Res; 2018 Mar; 32(6):640-647. PubMed ID: 28540745
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Cutting into the Substrate Dominance: Pharmacophore and Structure-Based Approaches toward Inhibiting Human Immunodeficiency Virus Reverse Transcriptase-Associated Ribonuclease H.
    Wang L; Sarafianos SG; Wang Z
    Acc Chem Res; 2020 Jan; 53(1):218-230. PubMed ID: 31880912
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Inhibitor ranking through QM based chelation calculations for virtual screening of HIV-1 RNase H inhibition.
    Poongavanam V; Steinmann C; Kongsted J
    PLoS One; 2014; 9(6):e98659. PubMed ID: 24897431
    [TBL] [Abstract][Full Text] [Related]  

  • 27. HIV-1 integrase and RNase H activities as therapeutic targets.
    Andréola ML; De Soultrait VR; Fournier M; Parissi V; Desjobert C; Litvak S
    Expert Opin Ther Targets; 2002 Aug; 6(4):433-46. PubMed ID: 12223059
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Design, synthesis, biochemical, and antiviral evaluations of C6 benzyl and C6 biarylmethyl substituted 2-hydroxylisoquinoline-1,3-diones: dual inhibition against HIV reverse transcriptase-associated RNase H and polymerase with antiviral activities.
    Vernekar SK; Liu Z; Nagy E; Miller L; Kirby KA; Wilson DJ; Kankanala J; Sarafianos SG; Parniak MA; Wang Z
    J Med Chem; 2015 Jan; 58(2):651-64. PubMed ID: 25522204
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Alizarine derivatives as new dual inhibitors of the HIV-1 reverse transcriptase-associated DNA polymerase and RNase H activities effective also on the RNase H activity of non-nucleoside resistant reverse transcriptases.
    Esposito F; Kharlamova T; Distinto S; Zinzula L; Cheng YC; Dutschman G; Floris G; Markt P; Corona A; Tramontano E
    FEBS J; 2011 May; 278(9):1444-57. PubMed ID: 21348941
    [TBL] [Abstract][Full Text] [Related]  

  • 30. 5-Hydroxypyrido[2,3-b]pyrazin-6(5H)-one derivatives as novel dual inhibitors of HIV-1 reverse transcriptase-associated ribonuclease H and integrase.
    Sun L; Gao P; Dong G; Zhang X; Cheng X; Ding X; Wang X; Daelemans D; De Clercq E; Pannecouque C; Menéndez-Arias L; Zhan P; Liu X
    Eur J Med Chem; 2018 Jul; 155():714-724. PubMed ID: 29940462
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Discovery, optimization, and target identification of novel coumarin derivatives as HIV-1 reverse transcriptase-associated ribonuclease H inhibitors.
    Kang D; Urhan Ç; Wei F; Frutos-Beltrán E; Sun L; Álvarez M; Feng D; Tao Y; Pannecouque C; De Clercq E; Menéndez-Arias L; Liu X; Zhan P
    Eur J Med Chem; 2021 Dec; 225():113769. PubMed ID: 34403976
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Combinatorial selection, inhibition, and antiviral activity of DNA thioaptamers targeting the RNase H domain of HIV-1 reverse transcriptase.
    Somasunderam A; Ferguson MR; Rojo DR; Thiviyanathan V; Li X; O'Brien WA; Gorenstein DG
    Biochemistry; 2005 Aug; 44(30):10388-95. PubMed ID: 16042416
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Data mining and molecular dynamics analysis to detect HIV-1 reverse transcriptase RNase H activity inhibitor.
    Ghafoor NA; Kırboğa KK; Baysal Ö; Süzek BE; Silme RS
    Mol Divers; 2024 Aug; 28(4):1869-1888. PubMed ID: 37561229
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Magnesium chelating 2-hydroxyisoquinoline-1,3(2H,4H)-diones, as inhibitors of HIV-1 integrase and/or the HIV-1 reverse transcriptase ribonuclease H domain: discovery of a novel selective inhibitor of the ribonuclease H function.
    Billamboz M; Bailly F; Lion C; Touati N; Vezin H; Calmels C; Andréola ML; Christ F; Debyser Z; Cotelle P
    J Med Chem; 2011 Mar; 54(6):1812-24. PubMed ID: 21366258
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Discovery of Benzisothiazolone Derivatives as Bifunctional Inhibitors of HIV-1 Reverse Transcriptase DNA Polymerase and Ribonuclease H Activities.
    Vázquez Rivera A; Donald H; Alaoui-El-Azher M; Skoko JJ; Lazo JS; Parniak MA; Johnston PA; Sluis-Cremer N
    Biomolecules; 2024 Jul; 14(7):. PubMed ID: 39062532
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Design, synthesis, and biological evaluation of 1,3-diarylpropenones as dual inhibitors of HIV-1 reverse transcriptase.
    Meleddu R; Cannas V; Distinto S; Sarais G; Del Vecchio C; Esposito F; Bianco G; Corona A; Cottiglia F; Alcaro S; Parolin C; Artese A; Scalise D; Fresta M; Arridu A; Ortuso F; Maccioni E; Tramontano E
    ChemMedChem; 2014 Aug; 9(8):1869-79. PubMed ID: 24850787
    [TBL] [Abstract][Full Text] [Related]  

  • 37. (3Z)-3-(2-[4-(aryl)-1,3-thiazol-2-yl]hydrazin-1-ylidene)-2,3-dihydro-1H-indol-2-one derivatives as dual inhibitors of HIV-1 reverse transcriptase.
    Meleddu R; Distinto S; Corona A; Bianco G; Cannas V; Esposito F; Artese A; Alcaro S; Matyus P; Bogdan D; Cottiglia F; Tramontano E; Maccioni E
    Eur J Med Chem; 2015 Mar; 93():452-60. PubMed ID: 25728026
    [TBL] [Abstract][Full Text] [Related]  

  • 38. HIV-1 RT-associated RNase H function inhibitors: Recent advances in drug development.
    Tramontano E; Di Santo R
    Curr Med Chem; 2010; 17(26):2837-53. PubMed ID: 20858167
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Recent progress in HIV-1 inhibitors targeting the entrance channel of HIV-1 non-nucleoside reverse transcriptase inhibitor binding pocket.
    Gu SX; Xiao T; Zhu YY; Liu GY; Chen FE
    Eur J Med Chem; 2019 Jul; 174():277-291. PubMed ID: 31051402
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Structure-based design of non-nucleoside reverse transcriptase inhibitors of drug-resistant human immunodeficiency virus.
    Mao C; Sudbeck EA; Venkatachalam TK; Uckun FM
    Antivir Chem Chemother; 1999 Sep; 10(5):233-40. PubMed ID: 10574178
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.